QuantuMDx Group Ltd.

Company Snapshot

Founded: 2008
Entity Type: Private
Region: U.K.
Headquarter: Newcastle upon Tyne, U.K.
Key Geographics: U.K., Europe, China
Corporate Address: Lugano Bldg, 57 Melbourne St Newcastle upon Tyne, NE1 2JQ U.K. Tel. +44-0-870-803-1234 www.quantumdx.com

Company Overview

Incorporated in 2008, Quantumdx has developed multiplex molecular testing solutions tailored to the point of care.

The point of care solutions (e.g., Q-POC PCR platforms) are engineered to the highest standards, ensuring portability, durability and ease of use. They are designed to be truly portable, powered by batteries, robust, intuitive, safe and user-friendly while delivering exceptional multiplex performance. This design enables healthcare professionals to conduct testing in diverse settings with confidence and efficiency.

Financial Highlights (FY 2023)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

QuantuMDx Group Ltd. In Reports

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics

BCC Research Market Analyst says global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029 at a CAGR of 5.9%.

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

Discover BCC Research's report on Next-generation Sequencing Market is steadily being integrated into clinical laboratory analysis, testing, and disease diagnostics in healthcare sectors globally.

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

BCC Research Market Report says clinical next-generation sequencing (NGS) should grow from $5.9 billion in 2020 to $22.9 billion by 2025 with a (CAGR) of 31.4%.

Company's Business Segments

  • Products : QuantuMDx delivers molecular diagnostics through the Q-POC platform and its expanding range of assays — enabling rapid, accurate, and accessible testing for STIs, AMR and more at the point of need.
  • Services : Technical support, Clinical Diagnostics, Others.

Applications/End User Industries

  • Molecular Diagnostics
  • Point Of Care
AI Sentiment